These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome. Kang SH, Lee HA, Kim M, Lee E, Sohn UD, Kim I. Am J Physiol Endocrinol Metab; 2017 Jun 01; 312(6):E495-E507. PubMed ID: 28246104 [Abstract] [Full Text] [Related]
14. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy. Liu L, Koike H, Ono T, Hayashi S, Kudo F, Kaneda A, Kagechika H, Manabe I, Nakashima T, Oishi Y. Proc Natl Acad Sci U S A; 2021 Aug 31; 118(35):. PubMed ID: 34426497 [Abstract] [Full Text] [Related]
15. PKB signaling and atrogene expression in skeletal muscle of aged mice. Gaugler M, Brown A, Merrell E, DiSanto-Rose M, Rathmacher JA, Reynolds TH. J Appl Physiol (1985); 2011 Jul 31; 111(1):192-9. PubMed ID: 21551011 [Abstract] [Full Text] [Related]
17. Dexamethasone exacerbates cisplatin-induced muscle atrophy. Sakai H, Kimura M, Tsukimura Y, Yabe S, Isa Y, Kai Y, Sato F, Kon R, Ikarashi N, Narita M, Chiba Y, Kamei J. Clin Exp Pharmacol Physiol; 2019 Jan 31; 46(1):19-28. PubMed ID: 30137654 [Abstract] [Full Text] [Related]
18. High-intensity resistance training attenuates dexamethasone-induced muscle atrophy. Krug AL, Macedo AG, Zago AS, Rush JW, Santos CF, Amaral SL. Muscle Nerve; 2016 May 31; 53(5):779-88. PubMed ID: 26355638 [Abstract] [Full Text] [Related]